PLASMODIUM VIVAX MALARIA

Clinical trials for PLASMODIUM VIVAX MALARIA explained in plain language.

Never miss a new study

Get alerted when new PLASMODIUM VIVAX MALARIA trials appear

Sign up with your email to follow new studies for PLASMODIUM VIVAX MALARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New malaria vaccine trial aims to stop recurrent fever

⭐️ VACCINE ⭐️ Not yet recruiting

This study tests an experimental vaccine called PvCS/Montanide ISA-51 to see if it can protect against P. vivax malaria, a major cause of recurrent fever and anemia. 72 healthy adults in Colombia will receive either the vaccine or a placebo, then be exposed to infected mosquitoes…

Matched conditions: PLASMODIUM VIVAX MALARIA

Phase: PHASE2 • Sponsor: Malaria Vaccine and Drug Development Center • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 09:00 UTC

PLASMODIUM VIVAX MALARIA

Get alerted when new PLASMODIUM VIVAX MALARIA trials appear

New malaria vaccine trial aims to stop recurrent fever